ANS pharmacology 2 Flashcards

(37 cards)

1
Q

○ Propranolol

A

adrenoceptor antagonist
§ Binds and inhibits B1 and B2
§ Inhibits B1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

propranolol effects

A

□ Decreases heard rate and contractility
□ Reduces cardiac output
□ Decrease blood pressure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

propranolol used for

A

□ Used to treat

® Angina, hypertension, arrythmias, post-myocardial infarction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

propanolol side effects

A

□ May exacerbate bronchoconstriction in asthma
□ May impair circulation in peripheral arterial disease
□ May worsen glycaemia control in diabetic patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

○ Metoprolol

A

§ Binds and inhibits B1 adrenoceptors

§ Reduces cardiac output and lowers blood pressure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

metoprolol used for

A

§ Used to treat

□ Angina, hypertension, arrythmias, post myocardial infarction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

metoprolol side effects

A

§ Doesn’t block b2 at usual doses
□ May be safer than propranolol in people treated for cardiovascular disease that also suffer for asthma, peripheral vascular disease or diabetes
§ But may block B2 at high doses
□ All beta adrenoceptor antagonists in patients where B2 receptor blockage is problematic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Drugs affecting muscarinic cholinoceptors

A
  • Available drugs often lack selectivity

minimal drugs available

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

2 muscarinic cholinoceptor agonists

A

pilocarpine

atropine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q
  • Pilocarpine
A

○ Muscarinic cholinoceptor agonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

pilocarpine used for

A

○ Delivered topically to the eye
§ Activate M3 receptors on the surface of the constrictor pupillae muscle
§ Constrict the pupil and promote the drainage of aqueous humous
§ Reduce intraocular pressure
○ Occasionally used clinically to treat glaucoma
§ Not first or second line treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q
  • Atropine
A

○ Blocks all muscarinic cholinoceptor subtypes

antagonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

atropine effects

A

§ Dries up secretions
□ Saliva, sweat, tears, gut and lung
§ Inhibits smooth muscle contraction
□ Gut, lungs and eye
§ Increases heart rate
○ Also crosses into CNS to block muscarinic receptors
§ Excitatory effects (restlessness, hyperactivity, increase body temp)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

atropine used for

A

○ Atropine is a frontline therapy for poisoning with anticholinesterase agents (pesticides, war gasses)
§ Blocks muscarinic cholinoceptor mediated side effects in CNS and PNS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q
  • Tiotropium
A

○ Used for chonic obstrictive pumonary disease (COPD)

○ Dilates the airways and reduces mucus secretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q
  • Tropicamide
A

○ Used for retinal examination

○ Relaxes ciliary muscle and iris sphincter

17
Q
  • Solifenacin
A

○ Used for urinary incontinence

○ Relaxes the smooth muscle of the bladder, which increases bladder capacity

18
Q

2 drugs inhibiting removal of NT

A

amphetamine and neostigmine

19
Q

§ Neostigmine

A

□ Blocks acetyl choline metabolism

20
Q

reuptake of noradrenaline

A

Most released NA undergoes neuronal reuptake, (by NA transporter, NAT)

21
Q

after reuptake of noradrenlaine

A

§ transported into vesicles by vesicular monoamine transporter, VMAT
§ Or inactivated by monoamine oxidase, MAO

22
Q

2 inhibitors of NA uptake and metabolism

A

amphetamine and pseudoephedrine

23
Q

amphetamine

A
  • induces reverse operation of NAT

○ Inhibits VMAT and MAO

24
Q

amphetamine effects

A

○ May cause vasoconstriction (a-AR) and increase in heart rate and contraction (b-AR)
§ Not used clinically for these effects on the autonomic nervous system
§ Used clinically for CNS effects
□ In children with ADHD

25
- Pseudoephedrine
○ Also increases NA release from adrenergic nerves ○ Use a nasal decongestant is now restricted § Can be converted into methamphetamine
26
Released Ach is metabolised by
enzymes AChE | § Acetylcholinesterase
27
- Anticholinesterase
○ Inhibitor of AchE | ○ Ach not metabolised and accumulates
28
- Anticholinesterase causes
○ Mimics stimulation of the parasympathetic nervous system | § Glandular secretion, smooth muscle contraction, slowing of HR
29
long actin anticholinesterases
war gasses/poisons | DUMBBELSS symptoms
30
DUMBBELSS
``` ® Diarrhoea ® Urination ® Miosis/muscle weakness ® Bronchorrhea/bronchoconstriction ® Bradycardia ® Emesis ® Lacrimation ® Salivation/sweating ® Seizures ```
31
killer Bs
® Excessive bronchochorrhea, bronchoconstriction or bradycardia can all cause death
32
therapy for long acting aticholinesterases
□ Atropine is a frontline therapy ® Because it can block the effects of Ach ® Can cross blood brain barrier and prevent CNS effects
33
medium acting anticholinesterases
□ Hours | □ Neostigmine
34
short acting anticholinesterases
□ Minutes | □ Edrophonium
35
clinical use of anticholinesterases in myasthenia graves
□ Autoimmune disease in which body attacks nicotinic receptors on skeletal muscle □ Extreme skeletal muscle weakness □ Loss of sensitivity to Ach can be overcome but increasing the concentration of Ach in the neuromuscular juction
36
diagnosis of myasthenia graves
® Edrophonium ◊ Used for diagnosis of myasthenia gravis ◊ When administered, it causes an increase in muscle strength in people with myasthenia gravis } Will not cause an increase in muscle strength in people without disease
37
chronic treatment of myasthenia graves
® Neostigmine ◊ Less useful because it needs to be given by injection ® Pyridostigmine ◊ Orally active